Executive Summary

Tackling the challenge of inappropriate antibiotic prescriptions for upper respiratory tract infections

Report from the Global Respiratory Infection Partnership
Meeting held 5th February 2016, Taplow House, Windsor, UK


  • Antimicrobial resistance (AMR) continues to be a global threat, with awareness of the problem still insufficient within certain constituencies and sectors in some countries.
  • Antibiotic prescribing rates for upper respiratory tract infection (URTI) are inappropriately high in most countries.
  • While many guidelines and action plans have been disseminated, there is still a lack of clear implementation guidance and unawareness on the appropriate use of antibiotics in URTI management.
  • Greater collaboration between organisations involved in tackling AMR, with clearer simplified messages, could help accelerate the translation of guidance into effective practice.
  • There is a need for greater awareness and education among patients and healthcare practitioners (HCPs) on: symptom duration, why antibiotics are not appropriate for management of the majority of URTIs and the suitable alternatives to managing symptoms.
  • Throughout 2016, GRIP will further its efforts in advancing the appropriate management of URTIs, through partnering with a range of national and international organisations.
  • A framework to measure and evaluate both global and local initiatives will be put in place in order to tailor future GRIP activations.